Previously [1] we reported that in vitro treatment with GGTI-298 induces a dose-dependent increase in the membrane expression of CD80 and CD86 costimulatory molecules in the murine melanoma cells B16F10 and an increase in CD86 in two human melanoma cell lines, including LB1319-MEL. This evidence concerns the gene CD80 and melanoma.